Menu

Aedes aegypti Genome Assembled From Scratch

Scientists use a new technique to piece together the mosquito’s full genome.

Mar 26, 2017
Diana Kwon

Aedes aegyptiCDC

Aedes aegypti is the main vector of the Zika virus. Now, scientists at the Baylor College of Medicine in Houston, Texas, and their colleagues have successfully constructed this mosquito’s 1.2 billion-letter genome using a new assembly technique. The team’s results were published last week (March 23) in Science.

The newly assembled A. aegypti genome could help researchers pinpoint genes in the mosquito that allow the virus to spread, better equipping scientists to fight future Zika outbreaks.  

The new 3-D genome assembly method, which the researchers have called Hi-C, uses information about how the genome folds to determine the order of its sequence. “I’ve been waiting to work with something like this for probably 20 years,” David Severson, a mosquito researcher at the University of Notre Dame in Indiana who was not involved in the work, told Nature.

Hi-C could also help make screening human genomes faster and more affordable, the authors proposed. Although the price of DNA sequencing has fallen in recent years, assembling whole genomes still remains an expensive and laborious task. This is because sequenced genes come in short snippets that are only hundreds of base pairs long, while chromosomes can reach lengths of up to hundreds of millions of base pairs.

“Sequencing a patient’s genome from scratch using 3-D assembly is so inexpensive that it’s comparable in cost to an MRI,” coauthor Olga Dudchenko, a postdoctoral fellow at Baylor, said in a statement. “Generating a de novo genome for a sick patient has become realistic.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.